A modified colorectal screening score for prediction of advanced neoplasia: A prospective study of 5744 subjects

Journal of Gastroenterology and Hepatology (Australia)

Volumn 33, Issue 1, 2018, Pages 187-194

  Sung, Joseph J Y ^a,b   Wong, Martin C S ^a,b   Lam, Thomas Y T ^a,b   Tsoi, Kelvin K F ^b   Chan, Victor C W ^a   Cheung, Wilson ^b   Ching, Jessica Y L ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

advanced colorectal neoplasia; body mass index; colorectal cancer screening; risk estimation; scoring algorithm

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY MASS; CANCER SCREENING; CHINESE; COHORT ANALYSIS; COLONOSCOPY; COLORECTAL CANCER; FEMALE; HONG KONG; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; VALIDATION STUDY; COLORECTAL TUMOR; EARLY CANCER DIAGNOSIS; RISK; RISK FACTOR; STATISTICAL MODEL;

BODY MASS INDEX; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; RISK; RISK FACTORS;

EID: 85039422111     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.13835     Document Type: Article

References (43)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010; 127: 2893–2917.
2. Hirabayashi Y, Tanaka S. Comparison of time trends in colorectal cancer incidence (1973–97) in East Asia, Europe and USA, from cancer incidence in five continents Vol. IV–VIII. Jpn. J. Clin. Oncol. 2007; 37: 325–327.
3. Sung JJY, Lau JYW, Goh KL, Leung WK. Asia Pacific working group on colorectal cancer. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 2005; 6: 871–876.
4. Wong CK, Lam CL, Poon JT et al. Direct medical costs of care for Chinese patients with colorectal neoplasia: a health care service provider perspective. J. Eval. Clin. Pract. 2012; 18: 1203–1210.
5. Nishihara R, Wu K, Lochhead P et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N. Engl. J. Med. 2013; 369: 1095–1105.
6. Wong MC, Tsoi KK, Ng SS et al. A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese. Aliment. Pharmacol. Ther. 2010; 32: 74–82.
7. Wong MC, Ching JY, Hirai HH et al. Perceived obstacles of Colorectal cancer screening and their associated factors among 10,078 Chinese participants. PLoS One 2013; 8: e70209.
8. Sung JJY, Ng SC, Chan FKL et al., Asia Pacific Working Group. An updated Asia Pacific consensus recommendations on colorectal cancer screening. Gut 2015; 64: 121–132.
9. Yeoh KG, Ho KY, Chiu HM et al. Asia-Pacific working group on colorectal cancer. The Asia-Pacific colorectal screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut 2011; 60: 1236–1241.
10. Corte C, Zhang L, Chen J et al. Validation of the Asia Pacific Colorectal Screening (APCS) score in a Western population: An alternative screening tool. J Gastroenterol Hepatol 2016; 31: 370.75.
11. Ben Q, An W, Jiang Y et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 2012; 142: 762–772.
12. Okabayashi K, Ashrafian H, Hasegawa H et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am. J. Gastroenterol. 2012; 107: 1175–1185.
13. Wong MC, Lam TY, Tsoi KK et al. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects. Gut 2014; 63: 1130–1136.
14. Fedirko V, Tramacere I, Bagnardi V et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann. Oncol. 2011; 22: 1958–1972.
15. Lieberman DA, Prindiville S, Weiss DG, Willett W, VA Cooperative Study Group 380. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003; 290: 2959–2967.
16. Cole BF, Logan RF, Halabi S et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J. Natl. Cancer Inst. 2009; 101: 256–266.
17. Flossmann E, Rothwell PM, British Doctors Aspirin Trial and the UK-TIA Aspirin Trial. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603–1613.
18. Wong MC, Lam TY, Tsoi KK et al. Predictors of advanced colorectal neoplasia for colorectal cancer screening. Am. J. Prev. Med. 2014; 46: 433–439.
19. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann. Intern. Med. 2003; 139: 959–965.
20. Institute of Medicine. Crossing the Quality Chasm: A new Heath System for the 21st Century. Washington, DC: National Academy Press, 2001.
21. Sheridan S, Harris R, Woolf S. Shared decision making about screening and chemoprevention. A suggested approach from the US Preventive Services Task Force. Am. J. Prev. Med. 2004; 26: 56–66.
22. Briss P, Rimer B, Reilley B et al. Task Force on Community Preventive Services. Promoting informed decisions about cancer screening in communities and healthcare systems. Am. J. Prev. Med. 2004; 26: 67–80.
23. Wong MC, Ching JY, Lam TY et al. Prospective cohort study of compliance with fecal immunochemical tests for colorectal cancer screening in Hong Kong. Prev. Med. 2013; 57: 227–231.
24. Wong MC, John GK, Hirai HW et al. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys. Cancer Causes Control 2012; 23: 1541–1548.
25. Levin TR. The importance of choosing colorectal cancer screening tests: comment on “Adherence to colorectal cancer screening”. Arch. Intern. Med. 2012; 172: 582–583.
26. Butterworth AS, Higgins JPT, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur. J. Cancer 2006; 42: 216–227.
27. Lin OS, Kozarek RA, Schembre DB et al. Risk stratification for colon neoplasia: screening strategies using colonoscopy and computerized tomographic colonography. Gastroenterology 2006; 131: 1011–1019.
28. Driver JA, Gaziano JM, Gelber RP, Lee IM, Buring JE, Kurth T. Development of a risk score for colorectal cancer in men. Am. J. Med. 2007; 120: 257–263.
29. Betés M, Muñoz-Navas MA, Duque JM et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am. J. Gastroenterol. 2003; 98: 2648–2654.
30. Tao S, Hoffmeister M, Brenner H. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening. Clin Gastrointest Hepatol 2014; 12: 478–485.
31. Kaminski MF, Polkowski M, Kraszewska E, Rupinski M, Butruk E, Regula J. A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut 2014; 63: 1112–1119.
32. Kim DH, Cha JM, Shin HP, Joo KR, Lee JI, Park DI. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea. J. Clin. Gastroenterol. 2015; 49: 41–49.
33. Kastrinos F, Allen JI, Stockwell DH et al. Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am. J. Gastroenterol. 2009; 104: 1508–1518.
34. Park Y, Freedman AN, Gail MH et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J. Clin. Oncol. 2009; 27: 694–698.
35. Freedman AN, Slattery ML, Ballard-Barbash R et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility. J. Clin. Oncol. 2009; 27: 686–693.
36. Wei EK, Colditz GA, Giovannucci EL, Fuchs CS, Rosner BA. Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am. J. Epidemiol. 2009; 170: 863–872.
37. Ma E, Sasazuki S, Iwasaki M et al. Japan Public Health Center-based Prospective Study Group. 10-Year risk of colorectal cancer: development and validation of a prediction model in middle-aged Japanese men. Cancer Epidemiol. 2010; 34: 534–541.
38. Cai QC, Yu ED, Xiao Y et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average-risk Chinese. Am. J. Epidemiol. 2012; 175: 584–593.
39. Wong MC, Wong SH, Ng SC, Wu JC, Chan FK, Sung JJ. Targeted screening for colorectal cancer in high-risk individuals. Best Pract Res Clin Gastroenterol. 2015; 29: 941–951.
40. Wen CP, Cheng TY, Tsai SPCHT, Hsu HL, Hsu CC et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr. 2009; 12: 497–506.
41. Kim Y, Kim Y, Lee S. An association between colonic adenoma and abdominal obesity: a cross-sectional study. BMC Gastroenterol. 2009; 9: 4.
42. Huang JL, Wang YH, Jiang J, Yu CP, Wu YL, Chen P, et al. The association between distal findings and proximal colorectal neoplasia: A systematic review and meta-analysis. Am J Gastroenterol 2017 doi: https://doi.org/10.1038/ajg.2017.130
43. Wong MC, Ching JY, Chiu H-M, Wu KC, Rerknimitr R, Li J, et al. Risk of colorectal neoplasia in individuals with self-reported family history: A prospective colonoscopy study from 16 Asia Pacific regions. Am J Gastroenterol 2016; 111: 1621–1629.